Menu
Close
We are committed to advancing personalized medicine and transforming healthcare through groundbreaking solutions, continuously expanding our technology to cover additional diseases and enhancing our platform's capabilities. Our strong partnerships and validated approach position us well for future growth and impact in the healthcare industry.
As we launch, our initial focus is on four critical types of cancer: lymphoma,melanoma, breast cancer, and lung cancer. However, this is merely the beginning. Our technology is inherently scalable, with the capability to replicate treatments for over 13,500diseases. Moving forward, we will continuously expand our portfolio to encompass morediseases, broadening the impact of our platform and redefining precision medicine.
Market
Validations